The Resident
Green Bay resident becomes first Wisconsinite to receive gene therapy treatment for hemophilia A
Hemophilia A is a genetic bleeding disorder that results from missing/insufficient levels of the blood clotting Factor VIII.
GREEN BAY, Wis. (WBAY) - A Green Bay resident has become the first Wisconsinite to receive a gene therapy treatment for hemophilia A since it was approved by the FDA in June.
David Novak, a patient at the Hemophilia Outreach Center in Green Bay, rece... [2569 chars]